Citigroup’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-30,071
| Closed | -$11K | – | 5126 |
|
2016
Q3 | $11K | Buy |
30,071
+1,385
| +5% | +$507 | ﹤0.01% | 4431 |
|
2016
Q2 | $14K | Sell |
28,686
-131,565
| -82% | -$64.2K | ﹤0.01% | 4390 |
|
2016
Q1 | $218K | Buy |
160,251
+100,143
| +167% | +$136K | ﹤0.01% | 3404 |
|
2015
Q4 | $89K | Buy |
60,108
+49,882
| +488% | +$73.9K | ﹤0.01% | 3670 |
|
2015
Q3 | $16K | Sell |
10,226
-2,075
| -17% | -$3.25K | ﹤0.01% | 4184 |
|
2015
Q2 | $21K | Sell |
12,301
-6,097
| -33% | -$10.4K | ﹤0.01% | 4249 |
|
2015
Q1 | $26K | Sell |
18,398
-12,137
| -40% | -$17.2K | ﹤0.01% | 4271 |
|
2014
Q4 | $46K | Buy |
30,535
+16,102
| +112% | +$24.3K | ﹤0.01% | 4145 |
|
2014
Q3 | $29K | Sell |
14,433
-10,672
| -43% | -$21.4K | ﹤0.01% | 4048 |
|
2014
Q2 | $77K | Sell |
25,105
-3,411
| -12% | -$10.5K | ﹤0.01% | 3268 |
|
2014
Q1 | $72K | Sell |
28,516
-27,539
| -49% | -$69.5K | ﹤0.01% | 3740 |
|
2013
Q4 | $278K | Buy |
56,055
+48,744
| +667% | +$242K | ﹤0.01% | 2873 |
|
2013
Q3 | $16K | Buy |
7,311
+7,111
| +3,556% | +$15.6K | ﹤0.01% | 4399 |
|
2013
Q2 | $0 | Buy |
+200
| New | – | ﹤0.01% | 5259 |
|